Acumen Pharmaceuticals, Inc.ABOSNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank20
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-100.20%
↓ 63% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-61.46%
Historical baseline
PeriodValue
2024-100.20%
2023-22.50%
2022-95.72%
2021-141.09%
2020-9.27%
20190.00%